The Effect of Prolonged ischemıa and anesthetıc Agents on Oxidative Stress
NCT ID: NCT06942650
Last Updated: 2025-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2022-01-01
2024-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer is:
Does anesthetic agents used will affect tourniquet-related oxidative stress and postoperative pain ?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Total Oxidant and Total Antioxidant Capacities in Low-Flow and High-Flow General Anesthesia
NCT05590312
Effects of Anesthesia Techniques on Tissue Oxygenation and Recovery in Lower Abdominal Surgery
NCT07102108
The Effects of Two Anesthetic Drugs on Some Enzyme Levels in Patients Undergoing Lower Extremity Surgery
NCT05950555
Comparison of Oxidants and Antioxidants in Breastmilk Under Different Anesthesia Protocols
NCT06811714
Anesthesia-Related Peroperative Critical Events
NCT06426940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients underwent routine anaesthetic examination during preoperative preparation. Informed consent was obtained from all patients. All patients were pressurised at a 90-degree angle to the knee with an algometer (J Tech Commender Echo Algometer, USA), and the average of three measurements was taken. The pressure was displayed in grams (gr) on the digital screen on the front of the devices. The first pressure value at which the patient felt pain was recorded in gr. Measurements were made at three levels (lower, middle, upper) 3-4 cm from the incision site. Measurements around the incision site
Patients were prepared for the operation according to the timing and conditions planned by the relevant clinic, and no preoperative or operative interventions were made regarding the method of operation or anesthesia. The oxidative load (HIF and DAF-16) \[ Human hypoxia-inducible factor 1α(HIF-1α) ELISA kit (pg/L), Human decay-accelerating factor(DAF/CD55)ELISA (pg/L) \] was measured from the centrifuged blood. In routine practice for knee arthroscopy operation under general anesthesia; ECG, pulsoximetry (O2 level measurement with finger probe), blood pressure measurement with cuff, tissue oximetry (NIRS, tissue oxygenation evaluation with probe attached to the relevant skin surface - dorsum of the foot) , patient monitoring was provided and the operation was started by positioning the patients after general anesthesia induction. Blood samples were taken from the foot to be operated on before the tourniquet was inflated and opened. Oxidative stress parameters were analyzed. Within the scope of the study, blood pressure values were recorded in the preoperative period (T0), while the patients were lying flat on the back after general anesthesia (T1), 5 minutes after the tourniquet was placed on the leg to be operated and inflated (T2), 15 minutes later (T3), 30 minutes later (T4), 60 minutes later (T5), before the tourniquet was opened (T6), and after the tourniquet was opened (T7). Tourniquet application was performed as routine, 20 mmHg above the initial blood pressure value, and the tourniquet was lowered in 1 second at the end of the operation. After the tourniquet was removed, d slope time (desaturation descent time), RR time (resaturation ascent time), delta StO2 (difference in tissue oximetry values between before and after anesthesia), hyperemic peak value, hyperemic period time after ischemia were recorded on the tissue oximetry trend monitor (Figure 2). Tourniquet time, duration of operation, duration of anaesthesia, patient's age, weight, height, body mass index, total anaesthetic agent usage, total tramadol administered (24-hour patient-controlled analgesia), and anaesthetic agent doses were recorded. Blood pressure and tissue oximetry values were obtained. Routine awakening and analgesia protocols were applied to the patients. Postoperative pain scale (VAS), operated and non-operated knee algometer values were measured at 1 hour, 3 hours, 6 hours, 12 hours, and 24 hours after awakening. Demographic outcomes, anaesthetic agent amounts, pain scores, HIF-1 alpha, and DAF measurements were analysed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* (American society of Anesthesiologist) ASA I-II status,
* undergoing knee arthroscopy.
Exclusion Criteria
* advanced chronic obstructive pulmonary disease,
* liver failure,
* renal failure,
* history of previous bypass,
* hemoglobinopathies,
* anemia,
* hypertensive patients,
* neurodegenerative diseases
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duzce University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
İlknur S YORULMAZ, Assoc. Prof.
Role: PRINCIPAL_INVESTIGATOR
Duzce University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
İlknur SuidiyeYORULMAZ
Düzce, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Duzce University
Identifier Type: OTHER
Identifier Source: secondary_id
2019/02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.